RP-6306 Chemical Structure oral PKMYT1 inhibitor - Repare Therapeutics, Inc., Ville St- Laurent, CA

oral PKMYT1 inhibitor

three Ph. I studies currently ongoing

initial screen of 560 known kinase inhibitors

J. Med. Chem.

Repare Therapeutics, Inc., Ville St- Laurent, CA

Context. RP-6306 is an oral protein kinase, membrane-associated tyrosine/threonine 1 (PKMYT1) Inhibitor being developed for various solid tumors. PKMYT1, together with WEE1, make up the WEE family of serine/threonine…


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.